893 results on '"O'Donnell, Denis E."'
Search Results
102. Physiological mechanisms of hyperventilation during human pregnancy
103. Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD
104. Mechanisms of activity-related breathlessness in healthy human pregnancy
105. Recent Advances in the Physiological Assessment of Dyspneic Patients with Mild COPD
106. Clinical Interpretation of Cardiopulmonary Exercise Testing: Current Pitfalls and Limitations
107. Oxygen supplementation during exercise improves leg muscle fatigue in chronic fibrotic interstitial lung disease
108. The Role of Spirometry in Evaluating Therapeutic Responses in Advanced COPD
109. Reviewer_3_v.1 – Supplemental material for Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial
110. Author_Response_1 – Supplemental material for Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial
111. Supplement – Supplemental material for Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial
112. Reviewer_1_v.1 – Supplemental material for Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial
113. Mechanisms of Orthopnoea in Patients with Advanced COPD.
114. Effects of human pregnancy and advancing gestation on respiratory discomfort during exercise
115. The Role of Tiotropium Bromide, a Long-Acting Anticholinergic Bronchodilator, in the Management of COPD
116. Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study
117. Deterioration of Nighttime Respiratory Mechanics in COPD
118. Normative Peak Cardiopulmonary Exercise Test Responses in Canadian Adults Aged ≥40 Years
119. Effects of human pregnancy on the ventilatory chemoreflex response to carbon dioxide
120. Long-Acting Muscarinic Antagonists in Asthma and COPD
121. Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
122. Physiologic Assessment of COPD
123. Decline of Resting Inspiratory Capacity in COPD: The Impact on Breathing Pattern, Dyspnea, and Ventilatory Capacity During Exercise
124. Response
125. Effects of BMI on Static Lung Volumes in Patients With Airway Obstruction
126. Breathing at Extremes
127. Morbidity and mortality associated with prescription cannabinoid drug use in COPD
128. Mechanisms of orthopnoea in patients with advanced COPD
129. Evaluation of Dynamic Respiratory Mechanical Abnormalities During Conventional CPET
130. Impaired cerebral oxygenation: a cause for exercise intolerance in patients with fibrotic interstitial lung disease?
131. Physiological phenotypes of COPD: the role of resting lung volumes
132. Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue?
133. The restrictive consequences of extreme obesity in men and women
134. Lung Function Testing in Chronic Obstructive Pulmonary Disease
135. Exercise Tolerance according to the Definition of Airflow Obstruction in Smokers
136. Dyspnea and Exercise Limitation in Mild COPD: The Value of CPET
137. Predictors of Opioid-related Adverse Pulmonary Events among Older Adults with Chronic Obstructive Pulmonary Disease
138. Are the “critical” inspiratory constraints actually decisive to limit exercise tolerance in COPD?
139. A Frame of Reference for Assessing the Intensity of Exertional Dyspnoea During Incremental Cycle Ergometry
140. Resting V′E/V′CO2 adds to inspiratory capacity to predict the burden of exertional dyspnoea in COPD
141. Integrating measurements of pulmonary gas exchange to answer clinically relevant questions
142. Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial
143. Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial
144. Small airway disease: when the “silent zone” speaks up.
145. The enigma of dyspnoea in COPD: A physiological perspective
146. Exertional dyspnoea–ventilation relationship to discriminate respiratory from cardiac impairment
147. Impact of a Specialized Ambulatory Clinic on Refractory Breathlessness in Subjects With Advanced COPD
148. On the complexities of measuring exercise “ventilatory efficiency” in obstructive lung diseases
149. Mechanisms of Exertional Dyspnea in Obesity: 192: 8:40 AM - 9:10 AM
150. Qualitative Components of Dyspnea during Incremental Exercise across the COPD Continuum.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.